MedTrace Logo

Organization Program of DiabEtes INsulIN ManaGement

NCT01338376 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2011-10-12

No results posted yet for this study

Summary

Diabetes is a common, costly condition associated with significant morbidity and mortality. Diabetes self-management education, the process of teaching individuals to manage their diabetes, has been considered an important part. The intensive education has the capacity to deliver effective interventions to a large number of people. The investigators may be able to redirect our efforts to diabetes care and education strategies that will have a positive impact on the optimization of glycemic control and the prevention of long-term complications of diabetes, reducing the subsequent human and health care costs.

Conditions

Interventions

BEHAVIORAL

Structured Education

All of the educators who are responsible for the intensive group will be trained with the standard contents before the study kick-off. * Educator Activities: insulin injection, SMBG instruction, self-learned manuals, periodic assessment for subjects, subject counseling, self-care education (healthy eating, exercise, weight control), prevention and treatment of hypoglycemia complication education ,newsletter delivered by SMS * Physician Activity: frequent insulin titration

BEHAVIORAL

Conventional Diabetes Education

The activities of the educators who are responsible for conventional group are identical with their routine clinical practice. * Educator Activities: insulin injection, SMBG instruction, healthy eating , prevention and treatment of hypoglycemia * Physician Activity: less frequent insulin titration

DRUG

Scilin®M30

Subjects will be treated with Scilin®M30 twice daily

Sponsors & Collaborators

  • Chinese Diabetes Society

    lead OTHER

Principal Investigators

  • Guo Xiao Hui, Professor · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01338376 on ClinicalTrials.gov